GlassScriptPhysician profile
Angel J Ross
NPI 1497394852
$571.39
in general payments reported to CMS, 2019-2025
18 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $141 · 2022: $98.28 · 2023: $135 · 2024: $57.43 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $331.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $133.47 | 2021-2025 | Wegovy |
| Pfizer INC. | $70.54 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $58.54 | 2023-2025 | Flumist Quadrivalent, Breztri |
| Dexcom, INC. | $33.48 | 2025 | Dexcom G6 Transmitter |
| Sanofi Pasteur INC. | $33.15 | 2023-2024 | |
| Stryker Corporation | $31.30 | 2025 | Clottriever Bold Catheter |
| Organon LLC | $23.34 | 2022 | |
| Seqirus USA INC | $22.69 | 2024 | Flucelvax |
| Ultragenyx Pharmaceutical INC. | $20.27 | 2023 | |
| Edwards Lifesciences Corporation | $20.26 | 2022 | |
| Abbott Laboratories | $19.27 | 2021 | |
| Phadia US INC. | $18.53 | 2023 | Immunocap |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.38 | 2021 | |
| Glaxosmithkline, LLC. | $14.61 | 2023 | Rotarix, Pediarix, Bexsero |
| Corium, LLC | $14.51 | 2023 | Azstarys |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biomarin Pharmaceutical INC. | $14.31 | 2025 | Voxzogo 1.2mg |
| Sanofi-Aventis U.S. LLC | $14.24 | 2021 | |
| Insulet Corporation | $13.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angel Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.